pre-seed
Stage
About
Axelyf develops RNA therapeutics for oncology and autoimmune diseases using a proprietary lipid nanoparticle delivery platform to enable precise and potent drug delivery.
Explore Axelyf's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.